Detalhe da pesquisa
1.
A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction.
J Pathol
; 262(3): 347-361, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235615
2.
ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway.
BMC Cancer
; 23(1): 480, 2023 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237279
3.
ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2.
Cell Mol Life Sci
; 79(8): 423, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35838828
4.
The activating transcription factor 2: an influencer of cancer progression.
Mutagenesis
; 34(5-6): 375-389, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31799611
5.
A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer.
Cancers (Basel)
; 14(1)2021 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008299
6.
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and Senescence.
Cancers (Basel)
; 13(21)2021 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771537
7.
Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells.
Cell Death Dis
; 10(6): 379, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097715
8.
Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma.
Cancer Lett
; 367(2): 147-56, 2015 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26225840